Cargando…
Muscle Loss after Chemoradiotherapy as a Biomarker of Distant Failures in Locally Advanced Cervical Cancer
This study aimed to evaluate whether computed tomography (CT)-based muscle measurement predicts distant failure in patients with locally advanced cervical cancer (LACC). Data from 278 patients with LACC who underwent chemoradiation therapy (CCRT) between 2004 and 2017 were analysed. Changes in the s...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139727/ https://www.ncbi.nlm.nih.gov/pubmed/32150938 http://dx.doi.org/10.3390/cancers12030595 |
_version_ | 1783518833021026304 |
---|---|
author | Lee, Jie Lin, Jhen-Bin Wu, Meng-Hao Chang, Chih-Long Jan, Ya-Ting Chen, Yu-Jen |
author_facet | Lee, Jie Lin, Jhen-Bin Wu, Meng-Hao Chang, Chih-Long Jan, Ya-Ting Chen, Yu-Jen |
author_sort | Lee, Jie |
collection | PubMed |
description | This study aimed to evaluate whether computed tomography (CT)-based muscle measurement predicts distant failure in patients with locally advanced cervical cancer (LACC). Data from 278 patients with LACC who underwent chemoradiation therapy (CCRT) between 2004 and 2017 were analysed. Changes in the skeletal muscle index (SMI), skeletal muscle density, and total adipose tissue index during CCRT were calculated from CT images taken at the baseline and after CCRT. The predictive capability of CT-based muscle measurement for distant failure was evaluated using Cox proportional hazards regression, Harrell’s concordance index (C-index), and time-dependent receiver operating characteristic curves. SMI loss ≥ 5% was independently associated with worse distant recurrence-free survival (DRFS) (HR: 6.31, 95% CI: 3.18–12.53; p < 0.001). The addition of muscle change to clinical models, including International Federation of Gynaecology and Obstetrics (FIGO) stage, lymph nodes, pathology, and squamous cell carcinoma-antigen, achieved higher C-indices (0.824 vs. 0.756; p < 0.001). Models including muscle change had superior C-indices than those including weight change (0.824 vs. 0.758; p < 0.001). The area under the curve for predicting 3-year DRFS was the highest for the muscle-loss model (0.802, muscle-loss model; 0.635, clinical model; and 0.646, weight-loss model). Our study demonstrated that muscle loss after CCRT was independently associated with worse DRFS and that integrating muscle loss into models including classical prognostic factors improved the prediction of distant failure. |
format | Online Article Text |
id | pubmed-7139727 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-71397272020-04-10 Muscle Loss after Chemoradiotherapy as a Biomarker of Distant Failures in Locally Advanced Cervical Cancer Lee, Jie Lin, Jhen-Bin Wu, Meng-Hao Chang, Chih-Long Jan, Ya-Ting Chen, Yu-Jen Cancers (Basel) Article This study aimed to evaluate whether computed tomography (CT)-based muscle measurement predicts distant failure in patients with locally advanced cervical cancer (LACC). Data from 278 patients with LACC who underwent chemoradiation therapy (CCRT) between 2004 and 2017 were analysed. Changes in the skeletal muscle index (SMI), skeletal muscle density, and total adipose tissue index during CCRT were calculated from CT images taken at the baseline and after CCRT. The predictive capability of CT-based muscle measurement for distant failure was evaluated using Cox proportional hazards regression, Harrell’s concordance index (C-index), and time-dependent receiver operating characteristic curves. SMI loss ≥ 5% was independently associated with worse distant recurrence-free survival (DRFS) (HR: 6.31, 95% CI: 3.18–12.53; p < 0.001). The addition of muscle change to clinical models, including International Federation of Gynaecology and Obstetrics (FIGO) stage, lymph nodes, pathology, and squamous cell carcinoma-antigen, achieved higher C-indices (0.824 vs. 0.756; p < 0.001). Models including muscle change had superior C-indices than those including weight change (0.824 vs. 0.758; p < 0.001). The area under the curve for predicting 3-year DRFS was the highest for the muscle-loss model (0.802, muscle-loss model; 0.635, clinical model; and 0.646, weight-loss model). Our study demonstrated that muscle loss after CCRT was independently associated with worse DRFS and that integrating muscle loss into models including classical prognostic factors improved the prediction of distant failure. MDPI 2020-03-05 /pmc/articles/PMC7139727/ /pubmed/32150938 http://dx.doi.org/10.3390/cancers12030595 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lee, Jie Lin, Jhen-Bin Wu, Meng-Hao Chang, Chih-Long Jan, Ya-Ting Chen, Yu-Jen Muscle Loss after Chemoradiotherapy as a Biomarker of Distant Failures in Locally Advanced Cervical Cancer |
title | Muscle Loss after Chemoradiotherapy as a Biomarker of Distant Failures in Locally Advanced Cervical Cancer |
title_full | Muscle Loss after Chemoradiotherapy as a Biomarker of Distant Failures in Locally Advanced Cervical Cancer |
title_fullStr | Muscle Loss after Chemoradiotherapy as a Biomarker of Distant Failures in Locally Advanced Cervical Cancer |
title_full_unstemmed | Muscle Loss after Chemoradiotherapy as a Biomarker of Distant Failures in Locally Advanced Cervical Cancer |
title_short | Muscle Loss after Chemoradiotherapy as a Biomarker of Distant Failures in Locally Advanced Cervical Cancer |
title_sort | muscle loss after chemoradiotherapy as a biomarker of distant failures in locally advanced cervical cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139727/ https://www.ncbi.nlm.nih.gov/pubmed/32150938 http://dx.doi.org/10.3390/cancers12030595 |
work_keys_str_mv | AT leejie musclelossafterchemoradiotherapyasabiomarkerofdistantfailuresinlocallyadvancedcervicalcancer AT linjhenbin musclelossafterchemoradiotherapyasabiomarkerofdistantfailuresinlocallyadvancedcervicalcancer AT wumenghao musclelossafterchemoradiotherapyasabiomarkerofdistantfailuresinlocallyadvancedcervicalcancer AT changchihlong musclelossafterchemoradiotherapyasabiomarkerofdistantfailuresinlocallyadvancedcervicalcancer AT janyating musclelossafterchemoradiotherapyasabiomarkerofdistantfailuresinlocallyadvancedcervicalcancer AT chenyujen musclelossafterchemoradiotherapyasabiomarkerofdistantfailuresinlocallyadvancedcervicalcancer |